This website is intended for healthcare professionals only

New summaries

Non-alcoholic fatty liver disease (NAFLD): assessment and management

National Institute for Health and Care Excellence

30 August 2016

Non-alcoholic fatty liver disease (NAFLD): assessment and management

Non-alcoholic fatty liver disease (NAFLD) has an estimated prevalence of between 20–30% of the general population and is increasing. While the average age of people with NAFLD-related non-alcoholic steatohepatitis is around 40–50 years, the growth of childhood obesity has increased the number of younger people with NAFLD, with some prevalence studies showing that up to 38% of obese children have evidence of NAFLD. With no currently licensed treatment and the falling average age of diagnosis, early detection and management of NAFLD in primary and secondary care is crucial.

This Guidelines summary provides recommendations on identification and diagnosis, and includes an algorithm on the assessment and monitoring of NAFLD in adults, children, and young people.

This clear summary of Public Health England's guideline on infection diagnosis and microbiological investigation of venous leg ulcers aims to provide a simple, effective, economical, and empirical approach to the management of venous leg ulcers when infection is suspected, and to minimise the emergence of antibiotic resistance in the community.

Zika virus infection: guidance for primary care


30 August 2016

Individuals infected with active Zika virus usually present with a mild illness lasting two to seven days. Symptoms include a combination of fever, joint pain, rash, conjunctivitis/red eyes, headache, muscle pain, and eye pain. Zika virus infection during pregnancy may be associated with foetal microcephaly and other central nervous system abnormalities. Zika virus infection has also been linked with Guillain-Barré syndrome. This Guidelines summary provides travel advice, and includes an algorithm for assessing pregnant women following travel from areas with active Zika virus transmission.

UK medical eligibility criteria for contraceptive use (UKMEC) guideline


02 August 2016

Modern contraceptives may be safe, but not all women are safe to use them. Preventing an unintended pregnancy can be vital, but must take into account the many factors influencing a woman's situation when she presents in primary care that could affect the safety of contraception. In this edition of the UKMEC guidance, factors such as a history of bariatric surgery, organ transplant, and rheumatoid arthritis have been included.This Guidelines summary covers the safety of contraceptive methods, their interactions with conditions women commonly present with in primary care, and the potential contraindications with ongoing treatment.
New articles

Working together: how can your clinical pharmacist help you?

By Sam Akram  |  

12 September 2016

Working together: how can your clinical pharmacist help you?

Sam Akram's article describes the changing role of pharmacists, the role of clinical pharmacists, and how nurses and pharmacists can work together to best manage patients in primary care.


Management of polymyalgia rheumatica
European League Against Rheumatism and American College of Rheumatology

Cirrhosis in over 16s: assessment and management
National Institute for Health and Care Excellence